Prague Med. Rep. 2023, 124, 421-434

https://doi.org/10.14712/23362936.2023.32

Evaluation of Retinal Nerve Fibre Layer Thickness and Choroidal Thickness in Parkinson Disease Patients

Kwang Sheng Ng1,2, Mohammad Hudzaifah-Nordin1,2,3, Sathyapriya Tamilarsan Sarah1,2,4, Wan Hitam Wan-Hazabbah1,2, Abd Halim Sanihah5

1Department of Ophthalmology and Visual Science, School of Medical Sciences, Universiti Sains Malaysia, Kubang Kerian, Malaysia
2Ophthalmology Clinic, Hospital Universiti Sains Malaysia, Universiti Sains Malaysia, Kubang Kerian, Malaysia
3Fakulti Perubatan, Universiti Sultan Zainal Abidin (UniSZA), Medical Campus, Jalan Sultan Mahmud, Kuala Terengganu, Terengganu, Malaysia
4Ophthalmology Clinic, Hospital Sultan Abdul Halim, Sungai Petani, Kedah, Malaysia
5Department of Medicine (Neurology), School of Medical Sciences, Universiti Sains Malaysia, Kubang Kerian, Malaysia

Received July 25, 2023
Accepted November 15, 2023

References

1. Abd Hamid, M. R., Wan Hitam, W. H., Abd Halim, S. (2021) Retinal nerve fiber layer and macular thickness in Parkinson’s disease patients. Cureus 13(7), e16224.
2. Atum, M., Demiryürek, B. E. (2021) Retinal morphological changes during the two years of follow-up in Parkinson’s disease. Ideggyogy. Sz. 74(1–2), 57–63. <https://doi.org/10.18071/isz.74.0057>
3. Bayhan, H. A., Aslan Bayhan, S., Celikbilek, A., Tanık, N., Gürdal, C. (2015) Evaluation of the chorioretinal thickness changes in Alzheimer’s disease using spectral-domain optical coherence tomography. Clin. Exp. Ophthalmol. 43(2), 145–151. <https://doi.org/10.1111/ceo.12386>
4. Bexci, M. S., Subramani, R. (2018) Decoding Parkinson’s associated health messages in social media pages by Malaysian service administrators. Malaysian Journal of Medical Research 2(4), 64–72. <https://doi.org/10.31674/mjmr.2018.v02i04.009>
5. Bodis-Wollner, I. (2013) Foveal vision is impaired in Parkinson’s disease. Parkinsonism Relat. Disord. 19, 1–14. <https://doi.org/10.1016/j.parkreldis.2012.07.012>
6. Borm, C. D. J. M., Visser, F., Werkmann, M., de Graaf, D., Putz, D., Seppi, K., Collerton, D., Thomas, A., Burn, D., McKeith, I., Mosimann, U. P. (2020) Seeing ophthalmologic problems in Parkinson disease. Results of a visual impairment questionnaire. Neurology 94(14), e1539–e1547. <https://doi.org/10.1212/WNL.0000000000009214>
7. Brown, G. L., Camacci, M. L., Kim, S. D., Grillo, S., Nguyen, J. V., Brown, D. A., Ullah, S. P., Lewis, M. M., Du, G., Kong, L., Sundstrom, J. M., Huang, X., Bowie, E. M. (2021) Choroidal thickness correlates with clinical and imaging metrics of Parkinson’s disease: A pilot study. J. Parkinsons Dis. 11(4), 1857–1868. <https://doi.org/10.3233/JPD-212676>
8. Chan, V. T. T., Sun, Z., Tang, S., Chen, L. J., Wong, A., Tham, C. C., Wong, T. Y., Chen, C., Ikram, M. K., Whitson, H. E., Lad, E. M., Mok, V. C. T., Cheung, C. Y. (2019) Spectral-domain OCT measurements in Alzheimer’s disease: A systematic review and meta-analysis. Ophthalmology 126(4), 497–510. <https://doi.org/10.1016/j.ophtha.2018.08.009>
9. Cubo, E., López Peña, M. J., Diez-Feijo, V. E., Pérez, G. O., Garcia, G. P., Araus, G. E., Prieto, T. R., Mariscal, P. N., Armesto, D. (2014) Lack of association of morphologic and functional retinal changes with motor and non-motor symptoms severity in Parkinson’s disease. J. Neural Transm. (Vienna) 121(2), 139–145. <https://doi.org/10.1007/s00702-013-1093-y>
10. Department of Statistics Malaysia (2021) Current population estimates, Malaysia, 2021.
11. Dorsey, E. R. (2018) Global, regional, and national burden of Parkinson’s disease, 1990–2016: A systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 17(11), 939–953. <https://doi.org/10.1016/S1474-4422(18)30295-3>
12. Dorsey, E. R., Bloem, B. R. (2018) The Parkinson pandemic – A call to action. JAMA Neurol. 75(1), 9–10. <https://doi.org/10.1001/jamaneurol.2017.3299>
13. Eraslan, M., Cerman, E., Yildiz Balci, S., Celiker, H., Sahin, O., Temel, A., Suer, D., Tuncer Elmaci, N. (2016) The choroid and lamina cribrosa is affected in patients with Parkinson’s disease: Enhanced depth imaging optical coherence tomography study. Acta Ophthalmol. 94(1), e68–e75. <https://doi.org/10.1111/aos.12809>
14. Evans, J. D. (1996) Straightforward Statistics for the Behavioral Sciences. Brooks/Cole Publishing, Pacific Grove.
15. Garcia-Martin, E., Larrosa, J. M., Polo, V., Satue, M., Marques, M. L., Alarcia, R., Seral, M., Fuertes, I., Otin, S., Pablo, L. E. (2014a) Distribution of retinal layer atrophy in patients with Parkinson disease and association with disease severity and duration. Am. J. Ophthalmol. 157(2), 470–478.e2. <https://doi.org/10.1016/j.ajo.2013.09.028>
16. Garcia-Martin, E., Rodriguez-Mena, D., Satue, M., Almarcegui, C., Dolz, I., Alarcia, R., Seral, M., Polo, V., Larrosa, J. M., Pablo, L. E. (2014b) Electrophysiology and optical coherence tomography to evaluate Parkinson disease severity. Invest. Ophthalmol. Vis. Sci. 55(2), 696–705. <https://doi.org/10.1167/iovs.13-13062>
17. Huang, L., Wang, C., Wang, W., Wang, Y., Zhang, R. (2021) The specific pattern of retinal nerve fiber layer thinning in Parkinson’s disease: A systematic review and meta-analysis. J. Neurol. 268(11), 4023–4032. <https://doi.org/10.1007/s00415-020-10094-0>
18. Indrieri, A., Pizzarelli, R., Franco, B., De Leonibus, E. (2020) Dopamine, alpha-synuclein, and mitochondrial dysfunctions in Parkinsonian eyes. Front. Neurosci. 14, 567129. <https://doi.org/10.3389/fnins.2020.567129>
19. Jankovic, J. (2008) Parkinson’s disease: Clinical features and diagnosis. J. Neurol. Neurosurg. Psychiatry 79(4), 368–376. <https://doi.org/10.1136/jnnp.2007.131045>
20. Kalia, L. V., Lang, A. E. (2015) Parkinson’s disease. Lancet 386, 896–912. <https://doi.org/10.1016/S0140-6736(14)61393-3>
21. Kamata, Y., Hara, N., Satou, T., Niida, T., Mukuno, K. (2022) Investigation of the pathophysiology of the retina and choroid in Parkinson’s disease by optical coherence tomography. Int. Ophthalmol. 42(5), 1437–1445. <https://doi.org/10.1007/s10792-021-02133-0>
22. Kaur, M., Saxena, R., Singh, D., Behari, M., Sharma, P., Menon, V. (2015) Correlation between structural and functional retinal changes in Parkinson disease. J. Neuroophthalmol. 35(3), 254–258. <https://doi.org/10.1097/WNO.0000000000000240>
23. Lim, S. Y., Norlinah, M. I., Santhi, D. P., Lee, M. K., Chee, K. Y., Shanthi, V., Tan, A. H., Chris, C. K. T., Kamal, A. A. (2012) 2012 Consensus Guidelines for the Treatment of Parkinson’s Disease. Available at: https://www.neuro.org.my/assets/guideline/2013PD_08012013.pdf
24. MacMahon, C. A. N., McComish, S. F., Fletcher, J. M., Caldwell, M. A. (2021) The pathogenesis of Parkinson’s disease: A complex interplay between astrocytes, microglia, and T lymphocytes? Front. Neurol. 12, 1–20.
25. Manjunath, V., Taha, M., Fujimoto, J. G., Duker, J. S. (2010) Choroidal thickness in normal eyes measured using Cirrus HD optical coherence tomography. Am. J. Ophthalmol. 150(3), 325–329.e1. <https://doi.org/10.1016/j.ajo.2010.04.018>
26. Moisan, F., Kab, S., Mohamed, F., Canonico, M., Le Guern, M., Quintin, C., Carcaillon, L., Nicolau, J., Duport, N., Singh-Manoux, A., Boussac-Zarebska, M., Elbaz, A. (2016) Parkinson disease male-to-female ratios increase with age: French nationwide study and meta-analysis. J. Neurol. Neurosurg. Psychiatry 87(9), 952–957. <https://doi.org/10.1136/jnnp-2015-312283>
27. Moschos, M. M., Chatziralli, I. P. (2018) Evaluation of choroidal and retinal thickness changes in Parkinson’s disease using spectral domain optical coherence tomography. Semin. Ophthalmol. 33(4), 494–497. <https://doi.org/10.1080/08820538.2017.1307423>
28. Nickla, D. L., Wallman, J. (2010) The multifunctional choroid. Prog. Retin. Eye Res. 29(2), 144–168. <https://doi.org/10.1016/j.preteyeres.2009.12.002>
29. Nowacka, B., Lubinski, W., Honczarenko, K., Potemkowski, A., Safranow, K. (2014) Ophthalmological features of Parkinson disease. Med. Sci. Monit. 20, 2243–2249.
30. Nowacka, B., Lubiński, W., Honczarenko, K., Potemkowski, A., Safranow, K. (2015) Bioelectrical function and structural assessment of the retina in patients with early stages of Parkinson’s disease (PD). Doc. Ophthalmol. 131(2), 95–104. <https://doi.org/10.1007/s10633-015-9503-0>
31. Oktem, C., Oktem, E., Kurt, A., Kilic, R. (2019) Does choroidal thickness change in Parkinson’s disease? Cesk. Slov. Neurol. N 82(6), 677–681. <https://doi.org/10.14735/amcsnn2019677>
32. Ortuño-Lizarán, I., Beach, T. G., Serrano, G. E., Walker, D. G., Adler, C. H., Cuenca, N. (2018) Phosphorylated α-synuclein in the retina is a biomarker of Parkinson’s disease pathology severity. Mov. Disord. 33(8), 1315–1324. <https://doi.org/10.1002/mds.27392>
33. Parkinson, J. (2002) An essay on the shaking palsy. J. Neuropsychiatry Clin. Neurosci. 14(2), 223–236. <https://doi.org/10.1176/jnp.14.2.223>
34. Pilat, A., McLean, R. J., Proudlock, F. A., Maconachie, G. D., Sheth, V., Rajabally, Y. A., Gottlob, I. (2016) In vivo morphology of the optic nerve and retina in patients with Parkinson’s disease. Invest. Ophthalmol. Vis. Sci. 57(10), 4420–4427. <https://doi.org/10.1167/iovs.16-20020>
35. Postuma, R. B., Berg, D., Stern, M., Poewe, W., Olanow, C. W., Oertel, W., Obeso, J., Marek, K., Litvan, I., Lang, A. E., Halliday, G., Goetz, C. G., Gasser, T., Dubois, B., Chan, P., Bloem, B. R., Adler, C. H., Deuschl, G. (2015) MDS clinical diagnostic criteria for Parkinson’s disease. Mov. Disord. 30(12), 1591–1601. <https://doi.org/10.1002/mds.26424>
36. Robbins, C. B., Thompson, A. C., Bhullar, P. K., Koo, H. Y., Agrawal, R., Soundararajan, S., Yoon, S. P., Polascik, B. W., Scott, B. L., Grewal, D. S., Fekrat, S. (2021) Characterization of retinal microvascular and choroidal structural changes in Parkinson disease. JAMA Ophthalmol. 139(2), 182–188. <https://doi.org/10.1001/jamaophthalmol.2020.5730>
37. Satue, M., Garcia-Martin, E., Fuertes, I., Otin, S., Alarcia, R., Herrero, R., Bambo, M. P., Pablo, L. E., Fernandez, F. J. (2013) Use of Fourier-domain OCT to detect retinal nerve fiber layer degeneration in Parkinson’s disease patients. Eye (Lond.) 27(4), 507–514. <https://doi.org/10.1038/eye.2013.4>
38. Satue, M., Rodrigo, M. J., Obis, J., Vilades, E., Gracia, H., Otin, S., Fuertes, M. I., Alarcia, R. C., Crespo, J. A., Polo, V., Larrosa, J. M., Pablo, L. E., Garcia-Martin, E. (2017) Evaluation of progressive visual dysfunction and retinal degeneration in patients with Parkinson’s disease. Invest. Ophthalmol. Vis. Sci. 58(2), 1151–1157. <https://doi.org/10.1167/iovs.16-20460>
39. Satue, M., Obis, J., Alarcia, R., Orduna, E., Rodrigo, M. J., Vilades, E., Gracia, H., Otin, S., Fuertes, M. I., Polo, V., Larrosa, J. M., Pablo, L. E., Garcia-Martin, E. (2018) Retinal and choroidal changes in patients with Parkinson’s disease detected by Swept-source optical coherence tomography. Curr. Eye Res. 43(1), 109–115. <https://doi.org/10.1080/02713683.2017.1370116>
40. Sengupta, P., Dutta, K., Ghosh, S., Mukherjee, A., Pal, S., Basu, D. (2018) Optical coherence tomography findings in patients of Parkinson’s disease: An Indian perspective. Ann. Indian Acad. Neurol. 21(2), 150–155. <https://doi.org/10.4103/aian.AIAN_152_18>
41. Simon, D. K., Tanner, C. M., Brundin, P. (2020) Parkinson disease epidemiology, pathology, genetics, and pathophysiology. Clin. Geriatr. Med. 36(1), 1–12. <https://doi.org/10.1016/j.cger.2019.08.002>
42. Tsironi, E. E., Dastiridou, A., Katsanos, A., Dardiotis, E., Veliki, S., Patramani, G., Zacharaki, F., Ralli, S., Hadjigeorgiou, G. M. (2012) Perimetric and retinal nerve fiber layer findings in patients with Parkinson’s disease. BMC Ophthalmol. 12, 54. <https://doi.org/10.1186/1471-2415-12-54>
43. Tysnes, O.-B., Storstein, A. (2017) Epidemiology of Parkinson’s disease. J. Neural Transm. (Vienna) 124(8), 901–905. <https://doi.org/10.1007/s00702-017-1686-y>
44. Urwyler, P., Nef, T., Killen, A., Collerton, D., Thomas, A., Burn, D., McKeith, I., Mosimann, U. P. (2014) Visual complaints and visual hallucinations in Parkinson’s disease. Parkinsonism Relat. Disord. 20(3), 318–322. <https://doi.org/10.1016/j.parkreldis.2013.12.009>
45. Weil, R. S., Schrag, A. E., Warren, J. D., Crutch, S. J., Lees, A. J., Morris, H. R. (2016) Visual dysfunction in Parkinson’s disease. Brain 139(11), 2827–2843. <https://doi.org/10.1093/brain/aww175>
46. Yu, J.-G., Feng, Y.-F., Xiang, Y., Huang, J.-H., Savini, G., Parisi, V., Yang, W.-J., Fu, X.-A. (2019) Retinal nerve fiber layer thickness changes in Parkinson disease: A meta-analysis. PLoS One 9(1), e85718. <https://doi.org/10.1371/journal.pone.0085718>
front cover

ISSN 1214-6994 (Print) ISSN 2336-2936 (Online)

Archive